Cited by 278Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Role of tau protein in Alzheimer’s disease: The prime pathological player

Muralidar, Shibi, Ambi, Senthil Visaga, Sekaran, Saravanan, Thirumalai, Diraviyam, Palaniappan, Balamurugan·2020·International Journal of Biological Macromolecules

Abstract

Alzheimer's disease (AD) is a prevalently found tauopathy characterized by memory loss and cognitive insufficiency. AD is an age-related neurodegenerative disease with two major hallmarks which includes extracellular amyloid plaques made of amyloid-β (Aβ) and intracellular neurofibrillary tangles of hyperphosphorylated tau. With population aging worldwide, there is an indispensable need for treatment strategies that can potentially manage this developing dementia. Despite broad researches on targeting Aβ in the past two decades, research findings on Aβ targeted therapeutics failed to prove efficacy in the treatment of AD. Tau protein with its extensive pathological role in several neurodegenerative diseases can be considered as a promising target candidate for developing therapeutic interventions. The abnormal hyperphosphorylation of tau plays detrimental pathological functions which ultimately lead to neurodegeneration. This review will divulge the importance of tau in AD pathogenesis, the interplay of Aβ and tau, the pathological functions of tau, and potential therapeutic strategies for an effective management of neuronal disorders.

Integrity signals

Registry

Crossref · 10.1016/j.ijbiomac.2020.07.327

Cites

302 of 302 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • α-Synuclein, heat shock proteins, immunophilins, and Pin1 regulate tau phosphorylation, aggregation, or degradation.

    “Besides, crosstalk with other proteins adds additional complexity; for example, α-synuclein, heat shock proteins, immunophilins, and the prolyl isomerase 1 (Pin1) have all been shown to regulate tau phosphorylation, aggregation, or degradation [48, 52].”
  • Tau pathology is associated with neuroinflammation, as pro-inflammatory cytokines can increase tau transcription and activate inflammatory pathways that exacerbate tau-related neurodegeneration.

    “Additionally, tau pathology is associated with neuroinflammation, as pro-inflammatory cytokines can increase tau transcription and activate inflammatory pathways that further exacerbate tau-related neurodegeneration [13,14].”
  • Hyperphosphorylation promotes tau aggregation into paired helical filaments and NFTs, which correlate strongly with clinical symptoms of AD.

    “This hyperphosphorylation promotes tau aggregation into paired helical filaments and NFTs, which correlate strongly with clinical symptoms of AD.”
  • The tau protein hypothesis focuses on hyperphosphorylation of tau leading to detachment from microtubules and formation of NFTs, a hallmark of AD.

    “The tau protein hypothesis focuses on the hyperphosphorylation of tau protein leading to its detachment from microtubules, resulting in the formation of neurofibrillary tangles (NFTs) which are a hallmark of AD.”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B.
Affiliations
SASTRA University (IN)
Corresponding author
Ambi, Senthil Visaga
Venue
International Journal of Biological Macromolecules
Publisher
Elsevier BV
Published
2020-11
Volume
163
Pages
1599-1617
ISSN
0141-8130 (ISSN-L)
OpenAlex
W3047818817
Cited by
278
References
302
Citations by year
2026: 50 · 2025: 58 · 2024: 69 · 2023: 53 · 2022: 25 · 2021: 19 · 2020: 4
FWCI
3.28
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Biological Macromolecules (publishedVersion)
  • PubMed (publishedVersion)
Funders
SASTRA-Deemed-to-be-University
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
tau protein, Alzheimer's disease, tau hyperphosphorylation, neurofibrillary tangles, amyloid-beta, amyloid plaques, tauopathy, neurodegeneration, dementia, therapeutic target
MeSH terms
Aging, Alzheimer Disease, Animals, Humans, Neurons, Phosphorylation, Amyloid beta-Peptides, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review